Skip to content
EUROCAM LOGO with slogan
Search
Donate
  • Home
  • Who we are
    • What is CAM
      • Benefits of CAM
      • Relevance for the EU
      • CAM modalities
      • CAM health professionals
      • CAM training and education in Europe
      • CAM regulation
      • CAM practice
    • What is IM
    • Affiliated organisations
    • Vision
    • Aims and objectives
    • Governance
    • Dedicated support team
  • What we do
    • MEP Interest Group on Integrative Medicine and Health
      • Guiding Principles MEP Interest Group
      • Official launch of the MEP Interest Group on Integrative Medicine & Health
    • EU4Health CSA demands to do more for health
      • Campaign for a stronger European health policy
      • EU health organisations react on cuts in EU health programme
    • COVID-19 and the immune system
    • Antimicrobial resistance
      • CAM-AMR Conference
      • Manifesto on antimicrobial resistance
    • CAM in the context of cancer
    • European Parliament 2019 -2024
      • EU4Health Programme
    • European Parliament 2014-2019
      • EU directives are not working for products used in CAM
      • CAM interest group European Parliament 2014-2019
        • CAM and musculoskeletal disorders
        • Ensuring the availability of CAM medicinal products
        • CAM – Reducing the need for antibiotics
        • CAM an investment in health
        • Cancer and the contribution of CAM
        • The need for research
        • Healthy ageing
      • CAM Conferences
        • ENVI committee workshop on CAM
        • CAM innovation and added value for the EU
      • EP docs on CAM
    • European Commission
      • Pharmaceutical Strategy
      • European Commission and CAM
      • EC docs on CAM
    • World Health Organization
      • WHO, European Programme of Work
  • Library
    • Publications
    • Position papers
      • The role of CAM in reducing AMR, position paper
      • Availability of CAM medicinal products, position paper
      • The role of CAM in the context of cancer, position paper
      • Research priorities for its use in citizens’ health, position paper
      • Healthy ageing, position paper
    • Cambrella reports
    • Knowledge exchange
    • Archive
  • Research
    • Complementary and Alternative Medicine
    • Acupuncture
    • Anthroposophic medicine
    • Ayurveda
    • Chiropractic
    • Herbal medicine
    • Homeopathy
    • Naturopathic medicine
    • Osteopathy
    • Shiatsu
    • Traditional Chinese Medicine
    • Yoga
  • Links
  • Health news
    • Health news
    • Members’ news
    • EUROCAM newsletters
  • Contact
    • Media kit
    • Factsheet
Donate
  • Home
  • Who we are
    • What is CAM
      • Benefits of CAM
      • Relevance for the EU
      • CAM modalities
      • CAM health professionals
      • CAM training and education in Europe
      • CAM regulation
      • CAM practice
    • What is IM
    • Affiliated organisations
    • Vision
    • Aims and objectives
    • Governance
    • Dedicated support team
  • What we do
    • MEP Interest Group on Integrative Medicine and Health
      • Guiding Principles MEP Interest Group
      • Official launch of the MEP Interest Group on Integrative Medicine & Health
    • EU4Health CSA demands to do more for health
      • Campaign for a stronger European health policy
      • EU health organisations react on cuts in EU health programme
    • COVID-19 and the immune system
    • Antimicrobial resistance
      • CAM-AMR Conference
      • Manifesto on antimicrobial resistance
    • CAM in the context of cancer
    • European Parliament 2019 -2024
      • EU4Health Programme
    • European Parliament 2014-2019
      • EU directives are not working for products used in CAM
      • CAM interest group European Parliament 2014-2019
        • CAM and musculoskeletal disorders
        • Ensuring the availability of CAM medicinal products
        • CAM – Reducing the need for antibiotics
        • CAM an investment in health
        • Cancer and the contribution of CAM
        • The need for research
        • Healthy ageing
      • CAM Conferences
        • ENVI committee workshop on CAM
        • CAM innovation and added value for the EU
      • EP docs on CAM
    • European Commission
      • Pharmaceutical Strategy
      • European Commission and CAM
      • EC docs on CAM
    • World Health Organization
      • WHO, European Programme of Work
  • Library
    • Publications
    • Position papers
      • The role of CAM in reducing AMR, position paper
      • Availability of CAM medicinal products, position paper
      • The role of CAM in the context of cancer, position paper
      • Research priorities for its use in citizens’ health, position paper
      • Healthy ageing, position paper
    • Cambrella reports
    • Knowledge exchange
    • Archive
  • Research
    • Complementary and Alternative Medicine
    • Acupuncture
    • Anthroposophic medicine
    • Ayurveda
    • Chiropractic
    • Herbal medicine
    • Homeopathy
    • Naturopathic medicine
    • Osteopathy
    • Shiatsu
    • Traditional Chinese Medicine
    • Yoga
  • Links
  • Health news
    • Health news
    • Members’ news
    • EUROCAM newsletters
  • Contact
    • Media kit
    • Factsheet
EP docs on CAM

Parliament docs on CAM

The EP documents on CAM area provides relevant resolutions.

  • Resolution on the status of non-conventional medicine A4-0075/97

Secretariat

Rue du Trône 194
1050 Brussels
Belgium

+31 631 948 408

secretariat(at)cam-europe.eu

member login

Secretary-General

Dr Ton Nicolai

+31 650 613 430

secretary-general(at)cam-europe.eu 

Communication & PR

Miranda Ruchtie and Sonja Maric

communication(at)cam-europe.eu

Terms & conditions

Privacy Statement

© 2018 EUROCAM